Background and Purpose-Oxidative stress is probably involved in neuronal damage induced by ischemia-reperfusion.
C erebral ischemia causes irreversible and fatal damage to part of the affected neurons, and the reperfusion and readmission of oxygen that follow may also be detrimental. 1, 2 During ischemia, high amounts of free radicals are formed by several mechanisms. 1 Increased free radical formation together with a reduced antioxidant defense causes oxidative stress that may play a pivotal role in the pathogenesis of stroke-associated neuronal injury. 1, 3 Currently, there is evidence from both animal and human studies demonstrating that the oxidative damage to membrane lipids and proteins is, indeed, increased during cerebral ischemia and reperfusion (IR). 4 -7 It is, however, difficult to determine which part of the damage is caused by hypoxia and which by reperfusion.
Antioxidant activity is known to reflect the altered redox balance of affected fluids, tissues, or organs in several pathological states. 8, 9 Therefore, antioxidant concentrations or measures of their activity have been used to estimate the amount of oxidative stress. Also, measures of the total antioxidant potential of biological fluids have been developed, and they have proved to be useful tools for estimating the antioxidant activity in clinical settings. 10 -12 During ischemia, cellular glutathione (GSH) is rapidly depleted, and this also impairs the regeneration of other antioxidants from their oxidized forms. Both blood plasma and cerebrospinal fluid (CSF) contain powerful chain-breaking antioxidants, such as ␣-tocopherol, ascorbic acid, uric acid, and protein-bound thiols. The concentrations and activities of these antioxidants may be important determinants of the IR-induced cerebral injury. The total antioxidant potential of CSF is substantially lower than that of plasma, and the major component of the potential in CSF seems to be ascorbic acid, 13 while in plasma it is uric acid. [11] [12] It has been shown 14 that the plasma and cerebral tissue levels of some antioxidants are decreased during IR in animals, supposedly as a sign of increased oxidative stress. It has also recently been reported 15 that patients with acute ischemic cerebral stroke have a lower plasma level of cholesterol-adjusted vitamin A, ␣-tocopherol, and carotenoids than healthy controls. High plasma concentrations of antioxidants have been associated with a decreased risk of cerebral stroke in some epidemiological cross-sectional studies, 16 but the antioxidant intervention trials to reduce the risk for stroke have not been all encouraging. 17, 18 Little is known about the role of antioxidant activity in the prevention of stroke-associated neuronal damage and impairment after cerebral stroke. By providing protection from oxidative damage during IR, antioxidants could, in principle, limit the size of the cerebral lesion; therefore, low antioxidant activity could contribute to poor functional recovery. We attempted to test this hypothesis by assessing the antioxidant activity of plasma and CSF in 22 cerebral right hemisphere ischemic stroke patients in whom a volumetric MRI analysis of the infarction area and neurological functional tests were also performed.
Subjects and Methods

Subjects
Thirty-three consecutive patients with acute infarction of the right cerebral hemisphere were initially recruited at the neurological ward of Tampere University Hospital, Tampere, Finland. The infarction was first diagnosed from clinical symptoms and CT scan on admittance. The diagnosis was then confirmed through MRI with a 0.5-T unit (General Electric Vectra) within 2 weeks (at days 4 to 14) from the stroke onset. The inclusion criteria were as follows: age not Ͼ75 years, right-handedness, no previous central nervous system diseases, no significant loss of hearing or sight, no significant physical handicap due to previous limb injury or disease, no other than current infarction-related cerebral changes in CT scanning, admittance to the neurological ward by the end of the third day after the infarction, and a level of consciousness of 0 or 1 by the NIH Stroke Scale 19 ("alert/not alert, but arousable by minor stimulation to obey, answer or respond"). Lumbar puncture for CSF antioxidant analysis could not be performed in 11 patients because of current treatment with heparin or warfarin (nϭ9), risk of cerebral herniation (nϭ1), or death (nϭ1): These subjects were excluded from further analysis. Thus, the final study group consisted of 22 patients (9 women, 13 men). All patients underwent a planned neurological rehabilitation program during their stay in the hospital.
The mean age of the included subjects was 63.1 years (median 64.5, SD 10.2, range 25 to 75 years). Three patients were current smokers. Nine patients had hypertonia, 7 had coronary heart disease, and 1 had type 2 diabetes mellitus. None of the patients admitted usage of any antioxidant supplements when asked by a physician.
All patients gave written informed consent, and the study was accepted by the Ethics Committee of the Tampere University Hospital.
Methods
The neurological evaluation included the NIH Stroke Scale (NIHSS), the Hand Motor Score (HMS), and the Barthel Index (BI). Each evaluation was conducted by the same neurologist (J.-P.A.). NIHSS is widely used to evaluate the neurological impairment resulting from stroke. 19 The theoretical maximum score in NIHSS is 34; a score of 0 represents a totally asymptomatic patient. The NIHSS does not include evaluation of hand motor function; it was, therefore, assessed with HMS 20 by a series of tests: testing extension of fingers, independent finger movements, holding a pen, pushing a syringe, unscrewing a small nut, and rotating a round item. A force transducer was used to measure the strength of hand squeeze and pinch grip force. Hand motor performance was scored using a scale from 0 (normal function) to 24 (total paresis). BI is a widely used assessment of patients' level of independence in activities of daily living. 21 BI assessment consists of several items that measure feeding, bathing, grooming, dressing, bowel and urine control, chair transfer, ambulation, and stair climbing. In BI the maximum score of 100 represents total independence and 0 a complete lack of independence.
The volumetric analysis of infarction size was conducted with digital MRI images and a semiautomatic segmentation algorithm in 14 patients. The newly developed segmentation algorithm and the Anatomatic TM software used have been described in detail elsewhere. 22 Lesion volume was manually estimated from MRI images in 7 patients because of insufficient quality of the images for semiautomatic analysis. In 1 patient the MRI data were not available, and thus the lesion volume could be determined in only 21 of the 22 patients.
Samples for antioxidant activity of blood plasma and CSF were taken at 2 points: The first sample was taken within the first 3 days after infarction (t1, mean 2.2 days), and the second sample was taken between the fourth and the twelfth day after infarction (t2, mean 7.3 days). The clinical examinations were performed at corresponding time points (Ϯ1 days) and at 3, 6, and 12 months after the stroke. Venous blood was obtained by antecubital venipuncture into EDTAcontaining vacuum tubes after an overnight fast. Plasma was immediately separated by centrifugation at 2800g for 10 minutes at 4°C. One hundred microliters of fresh plasma was mixed with 5% metaphosphoric acid before being frozen at Ϫ70°C for measurement of ascorbic acid. For the other antioxidant measurements, plasma was frozen and stored at Ϫ70°C; the storage time did not exceed 6 months.
Plasma total peroxyl radical-trapping potential (TRAP) was measured by a chemiluminescence-enhanced method, as has been described. 12,13,23 2,2Ј-Azobis [2-amidipropanone] hydrochloride (Polysciences) generates peroxyl radicals at a constant rate at ϩ37°C by thermal decomposition, and these radicals can be detected by a chemiluminescence reaction enhanced with luminol (Sigma Chemical Co). When a plasma or CSF sample is added, this reaction is inhibited for a time that is directly proportional to the total peroxyl radical-trapping antioxidative potential of the sample. 24 Provision is left for an unidentified fraction of measured TRAP, (TRAP Unid ), which is the difference between the measured plasma TRAP and TRAP Calc (TRAP Unid ϭTRAPϪTRAP Calc ).
The concentrations of uric acid and ascorbic acid were measured by high-performance liquid chromatography (HPLC) with an electrochemical detector. 25 ␣-Tocopherol was measured by a modified HPLC method, 26 in which ultraviolet detection was replaced with an electrochemical detector, set to oxidation potential of ϩ1.0 V (Bioanalytical Systems Inc). The CSF concentrations of ␣-tocopherol were below the detection limit of 1 mol/L, and therefore the TRAP Calc and TRAP Unid were not calculated for CSF. The protein thiol groups were determined as described. 27 
Statistics
The normality of the continuous variables was tested by the Shapiro-Wilk W test, after which comparisons between the antioxidant activity values at time points t1 and t2 were performed with the Student paired t test. An unpaired Student t test was used to compare independent groups. Log-transformed values of infarction volume were used in the statistical analysis. Correlation analyses were performed with the Pearson product-moment correlation matrix. Multiple regression analysis was used to identify determinants of the plasma and CSF TRAP. Computations were conducted with a microcomputer running Statistica for Windows 5.0 software (Statsoft Inc). All data in the text are given as meanϮ1 SD unless otherwise specified. A value of PϽ0.05 was considered significant.
Results
Individual baseline data for all study subjects is presented in Table 1 . The mean volume of the cerebral infarction was 10.2Ϯ11.8 cm 3 (range 0.1 to 44.7, median 8.6). The mean values for NIHSS, HMS, and BI at baseline according to lesion volume are presented in Table 2 . The volume of infarction had a significant correlation with the initial score in NIHSS (rϭ0.57, Pϭ0.007) and nearly significant correlations with the initial scores in HMS (rϭ0.43, Pϭ0.05) and BI (rϭϪ0.41, Pϭ0.07).
The antioxidant activities of plasma and CSF at time points t1 and t2 are presented in Table 3 . The mean values of these 2 assessments were used in further analyses, because the only statistically significant difference between t1 and t2 was observed in the plasma level of ␣-tocopherol, which decreased 6.4%. The measured individual antioxidant concentrations were entered in multiple regression models: the major determinant of plasma TRAP was uric acid (␤ϭ0. Plasma TRAP had a correlation with CSF TRAP (rϭ0.47, Pϭ0.03). There were no gender-specific differences in the plasma antioxidant concentrations or in the plasma TRAP. Men had higher CSF TRAP than women (Pϭ0.004) due to the higher CSF ascorbic acid and thiol concentrations (data not shown), but no other differences between males and females were observed. None of the antioxidant parameters were associated with the age of the study subjects or with smoking status. Patients with coronary heart disease had an increased plasma level of uric acid, but there were no other significant associations between the plasma antioxidant activity and the presence of hypertonia, diabetes mellitus (nϭ1), or coronary heart disease.
Plasma TRAP had an inverse correlation with the volume of the infarction (Figure, HT indicates hypertension; CHD, coronary heart disease; and DM, diabetes mellitus. *Missing data.
CSF antioxidant concentrations was associated with the infarction volume. Plasma TRAP had a significant or a nearly significant inverse correlation with the scores in NIHSS and HMS and a direct correlation with BI score at all time points after the stroke (Table 4) . This was largely due to similar correlations of plasma ascorbic acid, thiols, ␣-tocopherol, and the unidentified antioxidants with NIHSS, HMS, and BI (Table 4). In CSF, no consistent significant correlations between the antioxidant activity and neurological test scores were observed (data not shown). Patients with a lower-than-mean level of plasma TRAP had significantly poorer scores in NIHSS, HMS, and BI at almost all time points (Table 5) .
Discussion
This study demonstrates that the total antioxidant activity of plasma is associated with the volume of ischemic cerebral infarction and the degree of neurological impairment that follows. This was shown by correlations between plasma TRAP and MRI-based lesion volume and scores in neurological tests. Subjects with low plasma TRAP had a high lesion volume and a poor performance in neurological tests. The antioxidant activity of CSF, except for the CSF level of ascorbic acid, was not associated with the lesion volume or neurological findings.
The present study group consisted of 22 patients with newly diagnosed infarction of the right hemisphere. A similar location of the infarction in all patients allowed analysis of the association between the lesion size and the degree of neurological disability. Computed infarction volumes have been previously shown to possess an important prognostic value in the formation of neurological deficits after stroke, 28 which was also confirmed in this study by use of a new MRI-based technique. Our relatively small study group, however, included both very small and large infarctions, which increased the dispersion of measured variables.
TRAP is a useful estimate of the total antioxidant activity of a given biological fluid. Changes in plasma TRAP have been observed in various clinical situations, including aging, lung cancer, acute infection, immobilization, diabetes mellitus, and coronary heart disease. 12 Several modifications of the assay have been published, and they all share the same principle of producing peroxyl radicals at a steady rate. 11, 12 Because uric acid is present in high concentrations compared with other antioxidants in plasma, derivation of TRAP Calc by use of stoichiometric radical-trapping factors seems to be useful for analysis of the activity of other antioxidants. Although the individual antioxidants measured in this study form the majority of plasma TRAP, significant antioxidant activity remains unidentified (TRAP Unid ). Several candidates have been proposed to be responsible for TRAP Unid . These include bilirubin, protein-based groups other than thiols, ubiquinole-10, carotenoids, flavonoids, free amino acids, glucose, lipid hydroperoxides in the lipid peroxidation chain reaction itself, cholesterol, steroids, and melatonin. 29 Interestingly, of the antioxidant components of plasma, only TRAP Unid had a correlation with the infarction volume in the present study. TRAP Unid has been the only reactive component in some of our prior studies as well. 29 -32 It has been previously reported 15 that the cholesteroladjusted concentrations of carotenoids and ␣-tocopherol, but not the concentrations of selenium, thiols, or protein carbonyls, are lower in patients with ischemic stroke than in healthy controls. These data suggest that either the antioxidants in question are consumed or oxidized during the cerebral IR process or that their levels are lower already before the stroke. In the current study setting, measurement of the antioxidant activity prior to the stroke was not possible, and unaffected control subjects were not recruited. The levels of plasma and CSF antioxidants in the 
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stroke patients of the present study were, however, comparable to those seen in control subjects of previous studies conducted in our laboratory with the same methods and equipment. 12,13,23,29 -32 We were also unable to detect major changes in the antioxidant activity of plasma or CSF between the 2 early time points after the stroke. Nevertheless, the results of this study provide no information about the association between the antioxidant activity and the risk of stroke. Neither do the results prove that antioxidant activity is a determinant of severity of stroke-it can be vice versa. It is not fully known whether the free radicals during IR are formed in the vasculature, the neuronal parenchyma, or both. It has been shown that the endothelium is involved in the generation of free radicals during reoxygenation and that lipid peroxidation is increased in cerebral arterioles during cerebrovascular injury. 33 Ischemia may, however, lead to increased hydroxyl radical formation also in the parenchyma of the brain. 34 The relative importance of the mechanisms of free radical generation may vary between different areas of the lesion, which is not homogenous in nature with regard to the rate and completeness of both ischemia and reperfusion. It has been demonstrated that intravenous administration of an antioxidant entering the neuronal parenchyma is more effective in reducing infarction size than administration of an antioxidant acting on the endothelium of the cerebral microvasculature. 35 In our early MRI assessment, both the necrotic core and the edematous penumbra were included in the lesion volume, and it would have been interesting to reanalyze the association between antioxidant activity and the volume of the unrecovered brain mass at the end of the follow-up. This was not possible, however, due to resource limitations. The significance of the CSF antioxidant activity also remains to be further evaluated, because it was not associated with the severity of the stroke.
The treatment of cerebral stroke is still quite unsatisfactory, and new ways to improve the recovery and prognosis are needed. The results of this study suggest that there may be an association between the antioxidant activity of plasma and severity of ischemic stroke. Clinical evidence of the efficacy of antioxidants in prevention of neuronal damage after stroke is, however, lacking.
